Michael A. Panzara

Insider Reports History

Location
Bothell, WA
Signature
/s/ Grant Levine, attorney-in-fact
Transaction view
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Michael A. Panzara:

Form 4 holding Chief Medical Officer

IMMUNIC, INC.

Security class
Stock Option
Shares / value
300,000
Estimated value
Report date
24 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer, Head of Therapeutics Discovery and Development

Wave Life Sciences Ltd.

Security class
Share Option (right to buy)
Shares / value
60,000
Estimated value
Report date
25 Jul 2022
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

LeonaBio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
28,000
Estimated value
Report date
09 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Michael A. Panzara

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .